AnaptysBio Inc buy Guggenheim
Start price
28.05.25
/
50%
€18.40
Target price
28.05.26
€79.52
Performance (%)
126.09%
Price
19.12.25
€41.60
Summary
This prediction is currently active. With a performance of 126.09% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 28.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 9.474% | 9.474% |
| iShares Core DAX® | 0.299% | 4.557% |
| iShares Nasdaq 100 | 0.666% | 2.752% |
| iShares Nikkei 225® | -0.656% | 0.000% |
| iShares S&P 500 | 0.352% | 1.854% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $54.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat